Genmab
Pernille Erenbjerg serves as the Board Chair at KK Wind Solutions since January 2024 and has held the position of Non-Executive Board Member and Deputy Chair at Genmab since March 2015. Additional roles include Non-Executive Board Member at RTL Group since April 2021 and Adjunct Professor at Copenhagen Business School since January 2019. Erenbjerg has also been a Non-Executive Board Member and Deputy Chair at Millicom (Tigo) until May 2024, and previously chaired the Viaplay Group from May 2020 to July 2023. Earlier career highlights include serving as a Non-Executive Board Member at Nordea from March 2017 to March 2021 and leadership positions at TDC Group, including Group CEO and President from May 2003 to December 2018. Other notable board contributions were at DFDS and Det Kongelige Teater. Erenbjerg holds an MSc in Economics and a BSc in Economics from Copenhagen Business School, along with a CPA qualification.
This person is not in any teams
This person is not in any offices
Genmab
39 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.